Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Generic Sweden

58

 

SEK

 

+0,52 %

Mindre end 1K følgere

GENI

First North Stockholm

IT Services

Technology

Overview
Ownership
Investor consensus
Sammenligne
+0,52%
-1,86%
-5,84%
+5,45%
+25%
+14,62%
+9,02%
+192,93%
+144,78%

Generic Sweden is active in the IT sector. The company offers a platform for digital communication services that are integrated into customers' internal or external communication flows. The services are provided through a CPaaS (Communication Platform as a Service) model. Generic's customers are found in several sectors with a special position in alarm and security, healthcare and e-health, and e-commerce. The company was founded in 1993 and is headquartered in Stockholm.

Læs mere
Markedsværdi
712,94 mio. SEK
Aktieomsætning
1,86 mio. SEK
Omsætning
176,45 mio.
EBIT %
18,88 %
P/E
26,13
Udbytteafkast, %
2,76 %
Finanskalender
21.8
2025

Delårsrapport Q2'25

12.11
2025

Delårsrapport Q3'25

12.2
2026

Årsrapport '25

Alle
Eksterne analyser
ViserAlle indholdstyper
Eksterne analyser18.2.2025, 10.48

Generic: Ends 2024 in style - ABG

24% organic sales growth y-o-y Improved gross margin due to pricing and mix Opex flat y-o-y leads to 48% EBIT growth Q4: Sales growth of 24%, EBIT margin of 22.7% (19.0%) Generic continued its impressive comeback in Q4, where H1'24 profitability issues...

Generic Sweden
Eksterne analyser15.11.2024, 14.52

Generic: Strong quarter and outlook - ABG

24% organic sales growth y-o-y Improved gross margin due to price adjustments Opex growth to abate in the coming quarters Q3: Sales growth of 24%, EBIT margin of 20.6% (22.6%) In our view, Generic's Q3 results were impressive. Sales growth remained strong...

Generic Sweden
Eksterne analyser23.8.2024, 05.30

Generic: Strong growth, temporarily lower profitability - ABG

26% organic sales growth y-o-y Growth initiatives hurt profitability mid-term Pricing to act as a tailwind for gross margin in Q3 Q2: Sales growth of 26%, EBIT margin of 15.5% (20%) There was a similar trend in Generic's Q2 numbers as we saw in Q1, where...

Generic Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Eksterne analyser17.5.2024, 09.45

Generic: Prioritising growth over margins - ABG

22% organic sales growth y-o-y Lower than expected gross margin Price increases should help gross margin in Q2 Q1: Sales growth of 22%, EBIT margin of 16.3% (21.3%) Generic's Q1 numbers were quite eventful as there was a new strategic direction prioritising...

Generic Sweden
Eksterne analyser22.2.2024, 07.38

Generic: 2024 outlook still looks solid - ABG

12% organic sales growth y-o-y Opex increase and IAC affect Q4 Profitability assumptions down on slightly higher opex Q4: Sales growth of 12%, adj. EBIT margin of 19% (21.5%) Generic reported Q4 numbers were slightly behind our expectations. Net sales...

Generic Sweden
Eksterne analyser22.11.2023, 06.24

Generic: Solid Q3, softer outlook for '24e - ABG

15% organic sales growth y-o-y Inera volumes slightly delayed Minimal changes to long-term estimates Q3: Sales growth of 15%, EBIT margin of 22.6% (22.2%) Generic reported solid Q3 numbers with net sales of SEK 34.7m (+15% y-o-y, all organic), as the...

Generic Sweden
Eksterne analyser9.11.2023, 14.23

Generic: Inera deal sets up exciting 2024 - ABG

We expect a solid Q3 with 12% organic sales growth 15% EBIT growth y-o-y in Q3e Inera framework agreement behind our revisions Q3e: gradual recovery to continue Generic has historically showed a stable development that stems from a recurring SaaS offering...

Generic Sweden
Eksterne analyser30.8.2023, 05.33

Generic: Impressive profitability in Q2 - ABG

Solid sales growth at 10.4% y-o-y, all organic EBIT growth of 28% with excellent cost control Demand is holding up well into H2 Q2: Sales growth of 10.4%, EBIT margin of 20% (17.2%) Generic reported a solid quarter with net sales of SEK 34.6m (+10.4%...

Generic Sweden
Eksterne analyser23.5.2023, 05.27

Generic: Shows scalability despite lower sales growth - ABG

Sales growth below 10% again, but comps were tough Delivers 18% EBIT growth y-o-y DOCS sales have stabilised the gross margin Q1: Sales growth of 9% and an EBIT margin of 21.3% (19.6%) Generic reported Q1 net sales of SEK 34.6m (+9% y-o-y, all organic...

Generic Sweden
Eksterne analyser17.2.2023, 13.30

Generic: Sales growth re-established above 10% - ABG

Finding a new level of growth post COVID-19 Impressive profitability in Q4 Low churn confirmed, as expected Q4: Sales growth of 12% and an EBIT margin of 21.5% Generic reported solid Q4 results with net sales of SEK 34.2m (+12% y-o-y). Growth picked ...

Generic Sweden
Eksterne analyser30.8.2022, 07.12

Generic: A rare miss in Q2 - ABG

Slower sales growth than we have become used toWe lower long-term EBIT by 5%Lifted COVID-19 restrictions boost new salesQ2: Net sales +6% y-o-y, EBIT margin of 17.2% (20.4%)Generic reported Q2 net sales of SEK 31.3m (29.6), representing a slower growth...

Generic Sweden
Eksterne analyser21.2.2022, 10.47

Generic: Solid end to a fantastic year - ABG

Still growing sales >30% y-o-y in Q4Gross margin declining faster than expectedOpex will likely grow faster in ‘22e than ’20-‘21Q4: Sales +33% y-o-y, EBIT margin of 16.8% (15.9%)Generic reported Q4 net sales of SEK 30.5m (+33% y-o-y), 2% ahead of ABGSCe...

Generic Sweden
Eksterne analyser24.11.2021, 11.19

Generic: Solid Q3, but growth falls short of high hopes - ABG

39% sales growth y-o-y, EBIT +50% y-o-ySequential sales decline behind estimate revisions’22e EV/EBIT of 45x, 1.4% dividend yieldGeneric reported Q3 net sales of SEK 27.2m (+39% y-o-y), 4% below our forecast. The deviation stems from a higher sequential...

Generic Sweden
Eksterne analyser31.8.2021, 07.45

Generic: Q2 performance like clockwork - ABG

Two consecutive quarters with 47% y-o-y sales growthWe raise both sales and margin assumptions‘22e EV/EBIT of 38.2x, div yield of 1.6%Generic reported Q2 net sales of SEK 29.6m (20.2m), a second consecutive quarter with 47% y-o-y sales growth despite...

Generic Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.